Close Menu

NEW YORK (GenomeWeb) – Seegene today announced it has established Seegene Technologies, a new US subsidiary based in Concord, Calif.

The South Korean firm said it plans to enhance its sales in the US by directly managing existing clients and gaining new ones. Seegene will also pursue several US Food and Drug Administration submissions of reagents for multiplexed tests to detect respiratory and gastrointestinal infections.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.